ARTICLE | Company News
FDA accepts Abraxane NDA
May 10, 2004 7:00 AM UTC
The FDA accepted for filing an NDA from American Pharmaceutical Partners (APPX) for Abraxane to treat metastatic breast cancer. Abraxane is a nanoparticle comprising paclitaxel bound to albumin that a...